Elevated systolic blood pressure and risk of cardiovascular and renal disease: Overview of evidence from observational epidemiologic studies and randomized controlled trials

American Heart Journal

Volumn 138, Issue 3 II, 1999, Pages

  He, J ^a   Whelton, P K ^a  

^a TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0032881016     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70312-1     Document Type: Review

References (34)

1. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
2. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995;346:1647-53.
3. Collins R, Peto R, MacMahon SW, et al. Blood pressure, stroke, and CHD, II: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827-38.
4. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of CHD. Arch Intern Med 1993;153:578-81.
5. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic and cardiovascular risks: US population data. Arch Intern Med 1993;153:598-615.
6. Klag MJ, Whelton PK, Randall BL, et al. A prospective study of blood pressure and incidence of end-stage renal disease in 332,544 men. N Engl J Med 1996;334:13-8.
7. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
8. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
9. MRC Working Party. Medical research council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405-12.
10. Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension in Europe Trial Investigators. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.
11. American Heart Association. Heart and stroke facts: 1997 statistical supplement. Dallas: American Heart Association; 1997.
12. Stokes J III, Kannel WB, Wolf PA, et al. Blood pressure as a risk factor for cardiovascular disease: the Framingham Study: 30 years of follow-up. Hypertension 1989;13(suppl I):I-13-8.
13. Menotti A, Farchi G, Seccarecchia F. The prediction of coronary heart disease mortality as a function of major risk factors in over 30,000 men in the Italian RIFLE pooling Project: a comparison with the MRFIT primary screenees. J Cardiovasc Risk 1994;1:263-70.
14. Onat A, Dursunoglu D, Sansoy V. Relatively high coronary death and event rates in Turkish women: relation to 3 major risk factors in 5-year follow-up of cohort. Int J Cardiol 1997;61:59-77.
15. Kagan A, Yano K, Reed DM, et al. Predictors of sudden cardiac death among Hawaiian-Japanese men. Am J Epidemiol 1989;130:268-77.
16. Gagnon F, Dagenais GR, Robitaille NM, et al. Impact of systolic and diastolic blood pressure on ischaemic vascular diseases in French-Canadian men from 1974 to 1990. Can J Cardiol 1994;10:97-105.
17. Onat A, Dursunglu D, Sansoy V. Relative high coronary death and event rates in Turkish women: relation to 3 major risk factors in 5-year follow-up of cohort. Int J Cardiol 1997;61:69-77.
18. Tomas-Abadal L, Varas-Lorenzo C, Bernades-Bernat E, et al. Coronary risk factors and a 20-year incidence of coronary heart disease and mortality in a Mediterranean industrial population: the Manresa Study, Spain. Eur Heart J 1994;15:1028-36.
19. Lindenstrom E, Boysen G, Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. Am J Epidemiol 1995;142:1279-90.
20. Nielsen WB, Lindenstrom E, Vestbo J, et al. Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens 1997;10:634-9.
21. Petrovitch H, Curb D, Bloom-Marcus E. Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke 1995;26:25-9.
22. Lund Haheim L, Holme I, Hjermann I, et al. Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo study. J Hypertens 1995;13:909-13.
23. Klag MJ, Whelton PK, Randall RL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-8.
24. Perry HM Jr, Miller JP, Fornoff JR, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 1995;25:687-94.
25. Iseki K, Ikemiya Y, Fukiyama K. Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int 1996;55:S67-71.
26. Whelton PK, He J. Blood pressure reduction treatment trials. In: Hennekens C, Buring J, Furberg C, et al, editors. Clinical trials in cardiovascular disease. Philadelphia: WB Saunders Co; 1999. p. 341-59.
27. Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment for hypertension: a review. Hypertension 1989;13(suppl I):I-36-44.
28. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA 1967;202:1028-34.
29. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-52.
30. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 1974;229:409-18.
31. US Public Health Service Hospitals Cooperative Study Group. Treatment of mild hypertension: results of a 10-year intervention trial. Circ Res 1977;40:I-98-105.
32. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European working party on high blood pressure in the elderly trial. Lancet 1985;1:1349-54.
33. Cooper J, Warrender TS. Randomized trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986;293:1145-51.
34. The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2 413-46.